Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced a collaboration with MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, to expand MSCI's thematic index suite with the launch of new indexes that aim to capture long-term, cutting edge themes that will disrupt the life sciences, biotechnology and pharmaceutical industry groups. Royalty Pharma will provide expertise on various medical conditions, clinical trials, transformative therapies, and technologies that may lead to breakthrough medical treatments that will assist MSCI to design a classification framework and index m
